Registry for Cryoablation Procedures in Children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to audit the applications, success rates, safety profiles, complication rates, and efficacy of cryoablation procedures performed on pediatric patients. Cryoablation is a minimally invasive technique that uses extreme cold to destroy soft tissue or bone lesions, offering advantages such as faster recovery and reduced complications compared to traditional surgery. The study will include all children who are treated with percutaneous cryoablation, regardless of whether the procedure was technically feasible. The goal is to gather comprehensive data to better understand the use of cryoablation in a pediatric population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* all children in whom a clinical decision is made to treat with percutaneous cryoablation, to include those in whom cryoablation was not technically or clinically possible at any stage.

Exclusion Criteria:

* none

Where it's running

• Great
  London, United Kingdom Recruiting

Study contacts

• Principal investigator: Alex Barnacle, BM — Great Ormond Street Hospital, London, UK
• Study coordinator: Alex Barnacle, BM
• Email: Alex.Barnacle@gosh.nhs.uk
• Phone: +447810792517

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• PET imaging with [89Zr]DFO-starPEG for solid tumors

  We will test a new PET imaging tracer called [89Zr]DFO-starPEG in adults with measurable solid tumors to see if it highlights tumor uptake and is safe.

  Recruiting Phase 1 University of California, San Francisco · San Francisco, California · NCT06894745

• Cryoablation with Cadonilimab and Bevacizumab for Liver Cancer with Lung Metastases

  This study is testing if a new treatment that combines freezing liver tumors with two immunotherapy drugs can help patients with advanced liver cancer that has spread to the lungs feel better when other treatments haven't worked.

  Recruiting at 2 sites Sun Yat-sen University · Guanzhou, Guangdong and 1 other locations · NCT06265350

• Galvanize Pulsed Electric Field (PEF) treatment for soft tissue lesions

  This registry follows people with soft tissue lesions who receive Galvanize pulsed electric field (PEF) treatment to see how the device is used, whether it works, and whether it's safe.

  Recruiting at 11 sites Galvanize Therapeutics, Inc. · Gilbert, Arizona and 10 other locations · NCT05851430

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.